82 research outputs found

    Effects of outdoor air pollution on children with allergic rhinitis

    Get PDF
    The global worsening of air pollution has decreased the quality of life. Air pollutants can induce oxidative stress, epigenetic changes, and alterations to microRNA expression in the airway and skin, leading to immune dysregulation. Previous epidemiological studies suggest a strong association between outdoor environmental pollution and childhood allergic disease, especially allergic rhinitis (AR). Moreover, traffic-related air pollution has increased the severity and incidence of AR, and heavy traffic has been associated with an increased prevalence of AR. Thus, this review aimed to define outdoor environmental pollution and clarify the mechanisms by which air pollutants aggravate AR. In addition, we performed a systematic review and meta-analysis to summarize the findings of several domestic and international epidemiological and clinical studies about the effects of air pollution on AR in children.ope

    The incidence and risk factors of extrapulmonary manifestations in Mycoplasma pneumoniae pneumonia

    Get PDF
    Purpose Mycoplasma pneumoniae pneumonia (MP) is a major cause of community-acquired pneumonia (CAP) in children and is associated with extrapulmonary manifestations (EPM). The incidence and risk factors for EPM in children are unknown. Methods This was a retrospective study involving 65,243 pediatric patients with CAP between 2010 and 2015 at 23 nationwide hospitals in South Korea. Medical records were reviewed to collect information regarding the clinical characteristics, radiological results, and laboratory findings. Logistic regression with multivariate analysis was performed to evaluate the risk factors associated with EPM in MP. Results The incidence of EPM was 23.9%, including elevation of liver enzymes (18.1%), mucocutaneous manifestations (4.4%), proteinuria (4.1%), cardiovascular and neurological manifestations (0.4%), hematologic manifestations (0.2%), and arthritis (0.2%). Statistical analysis showed that mucocutaneous manifestations significantly increased with elevated alanine aminotransferase (adjusted odds ratio [aOR], 3.623; 95% confidence interval [CI], 1.933-6.790) and atopic sensitization (aOR, 2.973; 95% CI, 1.615โ€“5.475) and decreased with respiratory virus coinfection (aOR, 0.273; 95% CI, 0.084โ€“0.887). Elevated liver enzymes were significantly associated with elevated lactate dehydrogenase (aOR, 3.055; 95% CI, 2.257โ€“4.137), presence of pleural effusion (aOR, 2.635; 95% CI, 1.767โ€“3.930), and proteinuria with respiratory virus coinfection (aOR, 2.245; 95% CI, 1.113โ€“4.527). Conclusion Approximately 24% of pediatric patients with MP had various EPM. As the risk factors associated with each EPM were different, it is necessary to evaluate the various clinical aspects and findings of MP to predict and prepare for the occurrence of EPM.ope

    Adverse reactions to coronavirus disease 2019 vaccines in children and adolescents

    Get PDF
    The incidence of coronavirus diseases 2019 (COVID-19), including severe cases, has been increasing in both children and adolescents with the spread of the delta variant. COVID-19 vaccines have been identified to be effective in the prevention of COVID-19 transmission in children and adolescents and keeping schools open. However, adverse reactions associated with COVID-19 vaccination in children and adolescents contribute to parentsโ€™ hesitation to proceed with vaccination, especially due to serious, albeit rare, reactions. The results from COVID-19 vaccine clinical trials on the safety and efficacy of COVID-19 vaccines in children and adolescents are promising in terms of their effects on COVID-19 infection prevention. In the present study, we summarize the adverse reactions of COVID-19 vaccines in children and adolescents, based on the clinical trials, mainly including Pfizer-BioNTech and Moderna COVID-19 vaccines. In the Pfizer-BioNTech COVID-19 clinical trials, the most common local adverse reaction was pain at the injection site in 74.1%โ€“86%, depending on age, and the most common systemic adverse reaction was fatigue, followed by headache, myalgia, diarrhea, and fever with differences in the distribution according to age. There was no severe adverse reaction related to any COVID-19 vaccine in children and adolescents during the study period. In the mass vaccination program of COVID-19 in children and adolescent, myocarditis has rarely been diagnosed after COVID-19 vaccination, which most commonly occurred in boys after the second dose. Currently, Pfizer-BioNTech COVID-19 vaccines can be safely recommended in children and adolescents for the prevention of COVID-19 infection and the reduction in COVID-19 severity.ope

    KAAACI Allergic Rhinitis Guidelines: Part 1. Update in Pharmacotherapy

    Get PDF
    The prevalence of allergic rhinitis (AR) and the socioeconomic burden associated with the medical cost and quality of life (QOL) of AR have progressively increased. Therefore, practical guidelines for the appropriate management of AR need to be developed based on scientific evidence while considering the real-world environment, values, and preferences of patients and physicians. The Korean Academy of Asthma, Allergy and Clinical Immunology revised clinical guidelines of AR to address key clinical questions of the management of AR. Part 1 of the revised guideline covers the pharmacological management of patients with AR in Korea. Through a meta-analysis and systematic review, we made 4 recommendations for AR pharmacotherapy, including intranasal corticosteroid (INCS)/intranasal antihistamine (INAH) combination therapy, oral antihistamine/INCS combination therapy, leukotriene receptor antagonist treatment in AR patients with asthma, and prophylactic treatment for patients with pollen-induced AR. However, all recommendations are conditional because of the low or very low evidence of certainty. Well-designed and strictly executed randomized controlled trials are needed to measure and report appropriate outcomes. Copyright ยฉ 2023 The Korean Academy of Asthma, Allergy and Clinical Immunology.ope

    ๋””์ ค ์—”์ง„์˜ ์„ฑ๋Šฅ๊ณผ ๋ฐฐ๊ธฐ ์ตœ์ ํ™”๋ฅผ ์œ„ํ•œ ์—ฐ์†Œ ๋””์ž์ธ ์—ฐ๊ตฌ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ(๋ฐ•์‚ฌ) -- ์„œ์šธ๋Œ€ํ•™๊ต๋Œ€ํ•™์› : ๊ณต๊ณผ๋Œ€ํ•™ ๊ธฐ๊ณ„๊ณตํ•™๋ถ€, 2021.8. ์ด๊ด‘ํ˜ธ.์ตœ๊ทผ ๋‚ด์—ฐ๊ธฐ๊ด€ ์„ฑ๋Šฅํ–ฅ์ƒ์„ ์œ„ํ•œ ์—ฐ๊ตฌ๋Š” ์—ฐ๋น„, ๋ฐฐ์ถœ๋Ÿ‰, ์†Œ์Œ, ์ง„๋™ ๋“ฑ์˜ ์ธก๋ฉด์— ์ดˆ์ ์ด ๋งž์ถฐ์ง€๊ณ  ์žˆ๋‹ค. ์—ฐ๋น„๋Š” ์ง€๊ตฌ์˜จ๋‚œํ™”์— ์˜ํ–ฅ์„ ์ค€ ์ด์‚ฐํ™”ํƒ„์†Œ ๋ฐฐ์ถœ ๊ฐ์†Œ์™€ ๊ด€๋ จ์ด ์žˆ๋‹ค. ๋˜ํ•œ, ๋””์ ค ์—ฐ์†Œ๋กœ ์ธํ•œ ์งˆ์†Œ์‚ฐํ™”๋ฌผ๊ณผ ๊ทธ์„์Œ ๋ฐฐ์ถœ์€ ์ธ๊ฐ„์˜ ๊ฑด๊ฐ•์— ํ•ด๋กœ์šฐ๋ฉฐ ์ƒ๋ช…๊นŒ์ง€๋„ ์œ„ํ˜‘ํ•œ๋‹ค. ๋ฐฐ๊ธฐ ๊ฐ€์Šค์˜ ์œ ํ•ด์„ฑ์€ ๋งŽ์€ ๋‚˜๋ผ๋“ค์˜ ์ •๋ถ€๋“ค๋กœ ํ•˜์—ฌ๊ธˆ ์ฐจ๋Ÿ‰ ๋ฐฐ์ถœ ๊ทœ์ œ๋ฅผ ์—„๊ฒฉํ•˜๊ฒŒ ๋งŒ๋“ค๋„๋ก ๋™๊ธฐ๋ฅผ ๋ถ€์—ฌํ•˜๊ณ  ์žˆ๋‹ค. ์ตœ๊ทผ์—๋Š” ์‹คํ—˜์‹ค์˜ ์ธ์ฆ์น˜์™€ ๋„๋กœ์˜ ์‹ค์ œ ๋ฐฐ์ถœ๋Ÿ‰ ์ˆ˜์ค€ ๊ฐ„์˜ ์ฐจ์ด๋ฅผ ๊ณ ๋ คํ•ด Real-driving emissions ๊ทœ์ œ๊ฐ€ ์‹œํ–‰๋๋‹ค. ์†Œ์Œ ๊ณตํ•ด๋Š” ๋˜ํ•œ ์ธ๊ฐ„๊ณผ ๊ณต์ค‘ ๋ณด๊ฑด ๋ฌธ์ œ์˜ ๊ด€์ ์—์„œ ์ค‘์š”ํ•œ ์ฃผ์ œ์ด๋‹ค. ์—”์ง„์—์„œ ๋ฐœ์ƒํ•˜๋Š” ์—ฐ์†Œ ์†Œ์Œ์€ ์—”์ง„ ๋ณ€์ˆ˜ ๋ฐ ์—ฐ์†Œ ํŠน์„ฑ์— ์˜ํ•ด ์˜ํ–ฅ์„ ๋ฐ›๋Š” ์‹ค๋ฆฐ๋” ์••๋ ฅ ๋ฐฐ์ถœ์— ๋”ฐ๋ผ ๋‹ฌ๋ผ์ง„๋‹ค. ์ ์ ˆํ•œ ๋ถ„์‚ฌ ์ „๋žต ๋˜๋Š” ์—ฐ์†Œ ํ˜•ํƒœ๋Š” ์›ํ•˜๋Š” ์—ฐ์†Œ ์†Œ์Œ ์ˆ˜์ค€์„ ๋งŒ์กฑํ•˜๋„๋ก ์ตœ์ ํ™”ํ•  ์ˆ˜ ์žˆ๋‹ค. ์—”์ง„ ๊ฐœ๋ฐœ ๊ณผ์ • ์ค‘์— ์—ฐ๋น„, ๋ฐฐ๊ธฐ ๋ฐฐ์ถœ๋ฌผ ๋ฐ ์†Œ์Œ์˜ ๊ฐ ์„ฑ๋Šฅ์„ ์ตœ์ ํ™”ํ•˜๊ธฐ ์œ„ํ•œ ๋งŽ์€ ๋…ธ๋ ฅ๊ณผ ์‹œ๊ฐ„์ด ์†Œ๋ชจ๋œ๋‹ค. ์ตœ์ ์˜ ์„ฑ๋Šฅ์„ ์–ป์œผ๋ ค๋ฉด ์—ฐ์†Œ ๋ฐ ์—”์ง„ ์ž‘๋™ ๋ณ€์ˆ˜๋ฅผ ์ตœ์ ํ™”ํ•˜๊ธฐ ์œ„ํ•ด ๋งŽ์€ ์‹คํ—˜์ด ํ•„์š”ํ•˜๋‹ค. ์‹คํ—˜ ์—†์ด ์—”์ง„ ์„ฑ๋Šฅ์„ ์ตœ์ ํ™”ํ•˜๊ธฐ ์œ„ํ•ด ์ „์‚ฐ์œ ์ฒด์—ญํ•™ ์‹œ๋ฎฌ๋ ˆ์ด์…˜์„ ์ˆ˜ํ–‰ํ•˜๋ ค๋ฉด ๋†’์€ ๊ณ„์‚ฐ ๋น„์šฉ์ด ํ•„์š”ํ•˜๋‹ค. ๋”ฐ๋ผ์„œ, ๊ณ„์‚ฐ ๋น„์šฉ์ด ๋‚ฎ์€ 0-D ์—ฐ์†Œ ์ตœ์ ํ™” ๋ฐฉ๋ฒ•๋ก ์„ ๊ฐœ๋ฐœํ•˜๋Š” ๊ฒƒ์ด ์ค‘์š”ํ•˜๋‹ค. ์ด์ „ ์—ฐ๊ตฌ๋“ค์— ์˜ํ•œ 0-D ์—ฐ์†Œ ์ตœ์ ํ™” ๋ฐฉ๋ฒ•์€ ๋ถ„์‚ฌ ์ „๋žต ๋˜๋Š” ์—”์ง„ ๋ณ€์ˆ˜๋ฅผ ์ตœ์ ํ™”ํ–ˆ๋‹ค. ๊ฒฐ๊ณผ๋กœ ๋„์ถœ๋˜๋Š” ์—ฐ์†Œ๋Š” ๊ธฐ์กด ์—ฐ์†Œ ํ˜•์ƒ์˜ ๋ฒ”์œ„ ๋‚ด์— ์žˆ์œผ๋ฉฐ ์—ฐ์†Œ ํ˜•์ƒ์˜ ๋‹ค์–‘์„ฑ ์ธก๋ฉด์—์„œ ์‹คํ—˜์ ์œผ๋กœ ๋ณ€์ˆ˜๋ฅผ ์ตœ์ ํ™”ํ•˜๋Š” ๋ฐฉ๋ฒ•๊ณผ ๋‹ค๋ฅผ ๋ฐ” ์—†๋‹ค. ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ์›ํ•˜๋Š” ์„ฑ๋Šฅ์„ ์ž…๋ ฅ์œผ๋กœ, ์ตœ์  ์—ฐ์†Œ ๋ฐ ์—ฐ์†Œ ๋ณ€์ˆ˜๋ฅผ ์ถœ๋ ฅ์œผ๋กœ ๋„์ถœ๋˜๋Š” ์—ฐ์†Œ ๋””์ž์ธ ๋ฐฉ๋ฒ•๋ก ์„ ๊ฐœ๋ฐœํ•˜์˜€๋‹ค. ์ฒซ ๋ฒˆ์งธ ๋‹จ๊ณ„๋กœ ์—”์ง„ ์‹คํ—˜์„ ์ˆ˜ํ–‰ํ•˜์—ฌ ๋ฒ ์ด์Šค ์กฐ๊ฑด, EGR ์Šค์œ™, ํก๊ธฐ ์˜จ๋„ ๋ฐ ๋ƒ‰๊ฐ์ˆ˜ ์˜จ๋„ ์Šค์œ™ ์กฐ๊ฑด์—์„œ์˜ ์—ฐ๋น„ ๋ฐ ๋ฐฐ๊ธฐ ๋ฐฐ์ถœ์˜ ๊ธฐ๋ณธ ์„ฑ๋Šฅ์„ ํ‰๊ฐ€ํ•˜์˜€๋‹ค. ์ด ๊ฒฐ๊ณผ๋Š” ์—ฐ์†Œ ๋””์ž์ธ์— ํ™œ์šฉ๋˜๋Š” 0-D soot ๋ชจ๋ธ ์ˆ˜๋ฆฝ๊ณผ ์ตœ์ ํ™” ๊ณผ์ •์—์„œ ์ดˆ๊ธฐ ์กฐ๊ฑด์œผ๋กœ ์‚ฌ์šฉ๋˜์—ˆ๋‹ค. Soot ์ƒ์„ฑ ๋ชจ๋ธ์€ lift-off length์—์„œ ๋‹น๋Ÿ‰๋น„๋ฅผ ๊ณ„์‚ฐํ•˜๋Š” ๋‹จ์ˆœํ™”๋œ ์Šคํ”„๋ ˆ์ด ๋ชจ๋ธ์„ ๊ธฐ๋ฐ˜์œผ๋กœ ํ–ˆ๋‹ค. Lift-off length์—์„œ์˜ ๋‹น๋Ÿ‰๋น„๋Š” ๊ทธ์„์Œ ํ˜•์„ฑ ๋ชจ๋ธ์˜ ์ฃผ์š” ์š”์ธ ์ค‘ ํ•˜๋‚˜๋กœ ์‚ฌ์šฉ๋˜์—ˆ๋‹ค. ์—ฐ์†Œ ๋””์ž์ธ ๊ณผ์ •์—์„œ IMEP๋Š” ์—ฐ๋น„๋ฅผ ๋Œ€๋ณ€ํ•˜๋Š” ์ธ์ž๋กœ ์‚ฌ์šฉ๋˜์—ˆ๋‹ค. ์—ฐ์†Œ ์†Œ์Œ ํ‰๊ฐ€์—๋Š” ์—ฐ์†Œ ์†Œ์Œ ์ง€์ˆ˜๊ฐ€ ์‚ฌ์šฉ๋˜์—ˆ๋‹ค. NOx ๋ฐฐ์ถœ๋Ÿ‰ ์˜ˆ์ธก์—๋Š” ์ด์ „ ์—ฐ๊ตฌ๋กœ๋ถ€ํ„ฐ ๊ฐœ๋ฐœ๋œ 0-D NOx ๋ชจ๋ธ์ด ์ ์šฉ๋˜์—ˆ๋‹ค. ์—ฐ์†Œ ๋””์ž์ธ ๋ฐฉ๋ฒ•๋ก ์—์„œ, ์‹ค๋ฆฐ๋” ๋‚ด ์••๋ ฅ ๊ณ„์‚ฐ์— ํ•„์š”ํ•œ ๋ณ€์ˆ˜๋Š” ํก๊ธฐ ์••๋ ฅ, ๋žŒ๋‹ค ๋ฐ ์งˆ๋Ÿ‰ ์—ฐ์†Œ์œจ์ด์—ˆ๋‹ค. ์งˆ๋Ÿ‰ ์—ฐ์†Œ์œจ์€ ๊ธฐ์กด์— ๋„๋ฆฌ ์‚ฌ์šฉ๋˜๋Š” ์œ„๋ฒ  ํ•จ์ˆ˜์™€ ์—ฐ์†Œ์ƒ์— ๋Œ€ํ•œ ์ƒˆ๋กœ์šด ์ ‘๊ทผ๋ฒ•์œผ๋กœ ๋‹คํ•ญ์‹ ํ•จ์ˆ˜๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๊ฒฐ์ •๋˜์—ˆ๋‹ค. ์‹ค๋ฆฐ๋” ๋‚ด ๊ณต๊ธฐ์˜ ์งˆ๋Ÿ‰๊ณผ EGR์œจ์€ ์ดˆ๊ธฐ ์กฐ๊ฑด์œผ๋กœ ๊ฒฐ์ •๋œ ํก๊ธฐ ์••๋ ฅ, ์˜จ๋„, ๋žŒ๋‹ค ๋ฐ ํ™”ํ•™ ๋ฐ˜์‘ ๋ฐฉ์ •์‹์œผ๋กœ ๊ณ„์‚ฐ๋˜์—ˆ๋‹ค. ์—ฐ์†Œ ์ค‘์˜ ๊ธฐ์ฒด ์กฐ์„ฑ๋น„๋Š” polytropic ์ง€์ˆ˜ ๋ฐ ์—ฌ๋Ÿฌ ์—ด์—ญํ•™์  ๋ณ€์ˆ˜์˜ ๊ณ„์‚ฐ์„ ์œ„ํ•ด ๊ณ„์‚ฐ๋˜์—ˆ๋‹ค. ์‹ค๋ฆฐ๋” ๋‚ด ์••๋ ฅ์€ polytropic ๊ณผ์ •๊ณผ ์—ด ๋ฐœ์ƒ๋ฅ ์œผ๋กœ ๊ณ„์‚ฐ๋˜์—ˆ๋‹ค. ์ตœ์ ํ™” ๊ณผ์ •์—์„œ ์—ฐ์†Œ ๋””์ž์ธ ๋ฐฉ๋ฒ•์— ์‚ฌ์šฉ๋œ ์ตœ์ ํ™” ์•Œ๊ณ ๋ฆฌ์ฆ˜์€ ์ œํ•œ๋œ ๋น„์„ ํ˜• ๋‹ค๋ณ€๋Ÿ‰ ํ•จ์ˆ˜(Interior-point ๊ธฐ๋ฒ•)์™€ ์ž…์ž ๊ตฐ์ง‘ ์ตœ์ ํ™”์˜ ์ตœ์†Œ๊ฐ’์ด์—ˆ๋‹ค. ๊ฒฝ๊ณ„ ์กฐ๊ฑด๊ณผ ์ œ์•ฝ ์กฐ๊ฑด์€ ์ตœ์ ํ™” ๊ณผ์ •์˜ ํšจ์œจ์ ์ธ iteration์„ ์œ„ํ•ด ๊ฒฐ์ •๋˜์—ˆ๋‹ค. ์ตœ์ ํ™”๋ฅผ ์œ„ํ•œ ๋ชฉ์  ํ•จ์ˆ˜์˜ ๊ธฐ๋ณธ ํ˜•ํƒœ๋Š” ์ž…๋ ฅ์œผ๋กœ ์‚ฌ์šฉ๋œ ์›ํ•˜๋Š” ์„ฑ๋Šฅ์„ ๊ฐ€์ง€๋Š” ํŠน์ •ํ•œ ์—ฐ์†Œ๋ฅผ ์ฐพ์„ ์ˆ˜ ์žˆ๊ฒŒ ํ–ˆ๋‹ค. ๋ชฉํ‘œ ์„ฑ๋Šฅ์„ ์ตœ๋Œ€ํ™”ํ•˜๋Š” ๋‹ค์–‘ํ•œ ๋””์ž์ธ ๋ชฉ์ ์— ๋”ฐ๋ผ ๋ชฉํ‘œ ํ•จ์ˆ˜๋Š” ๋ณ€ํ˜•๋˜์–ด ์‚ฌ์šฉ๋˜์—ˆ๋‹ค. ์—ฐ์†Œ ๋””์ž์ธ์˜ ๊ฒฐ๊ณผ๋Š” ๋‹ค์–‘ํ•œ ์šด์ „ ์˜์—ญ์—์„œ MFB์™€ ๋ชฉ์  ํ•จ์ˆ˜์— ๋”ฐ๋ผ ์—ฐ๊ตฌ๋˜์—ˆ๋‹ค. WLTP ์šด์ „ ์˜์—ญ์—์„œ ์ •์ƒ ์ƒํƒœ ์—ฐ์†Œ๋“ค์„ ๋””์ž์ธํ•˜์—ฌ ์—ฐ์†Œ ๋””์ž์ธ ๋ฐฉ๋ฒ•๋ก ์„ WLTP์— ์ ์šฉํ•˜์˜€๋‹ค. ์ ์šฉ ๊ฒฐ๊ณผ, WLTP ์ค‘ ์—ฐ๋ฃŒ ์†Œ๋ชจ๋Ÿ‰์€ 4.7% ๊ฐ์†Œ๋˜์—ˆ๋‹ค. NOx์™€ soot ๋ฐฐ์ถœ์€ ๊ฐ๊ฐ 44.7%์™€ 60.7%์˜ ๊ฐ์†Œ์œจ์„ ๋ณด์˜€๋‹ค. ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ์›ํ•˜๋Š” ์„ฑ๋Šฅ์˜ ์—ฐ์†Œ๋ฅผ ๋„์ถœํ•˜๋Š” 0-D ์—ฐ์†Œ ์‹œ๋ฎฌ๋ ˆ์ด์…˜ ๋ฐ ์ตœ์ ํ™” ๋ฐฉ๋ฒ•์„ ์ œ๊ณตํ•˜์˜€๋‹ค. ์ด ์—ฐ๊ตฌ๋Š” ์›ํ•˜๋Š” ์„ฑ๋Šฅ ํ˜น์€ ์ตœ์ ํ™”๋œ ์„ฑ๋Šฅ์„ ๊ฐ€์ง€๋Š” ์—ฐ์†Œ์ƒ์„ ์—ด์—ญํ•™์ ์ธ ์กฐ๊ฑด๋“ค๊ณผ ํ•จ๊ป˜ ์ œ์‹œํ•  ์ˆ˜ ์žˆ์–ด ์ด๋ฅผ ๋ฐ”ํƒ•์œผ๋กœ ๊ธฐ์กด์˜ ์—ฐ๊ตฌ ๋ฐฉ๋ฒ•๊ณผ ๋‹ค๋ฅธ ๋ชฉํ‘œ ์—ฐ์†Œ๋ฅผ ๊ตฌํ˜„ํ•˜๊ธฐ ์œ„ํ•œ ์—”์ง„๊ณผ ์—ฐ์†Œ ์ „๋žต ๊ฐœ๋ฐœ ๋ฐฉํ–ฅ์„ ์ œ์‹œํ•  ์ˆ˜ ์žˆ๋‹ค.Recently, the researches for improving the performance of the internal combustion engines have been focused on the respect of thermal efficiency, emissions, noise and vibration. The thermal efficiency is related with decreasing carbon dioxide (CO2) emission that has affected global warming. Also, nitrogen oxides (NOx) and soot emissions from diesel combustion are harmful for human. The harmfulness of exhaust gases has motivated governments of many countries to make vehicle emission regulations stringent. Recently, real-driving emissions (RDE) regulation was enforced, considering the discrepancy between the certified values in laboratory and the actual emission levels on the road. Noise pollution is also important in the perspective of human and public health problem. The combustion noise from the engine depends on the cylinder pressure excitation, which is affected by the engine parameters and combustion characteristics. Proper injection strategies or combustion shape can be optimized to meet the desired combustion noise level. The engine development process takes a lot of effort and time to optimize each performance of thermal efficiency, emissions and noise. To achieve desired optimal performance, many trials and errors and experiments are required to optimize combustion and engine operating parameters. As an optimization tool, computational fluid dynamics (CFD) simulation needs substantial calculation cost. Thus, it is important to develop 0-D combustion optimization methodology that has low calculation cost. Previously studied 0-D combustion optimization methods have been optimized the injection strategy or engine parameters. The resulting combustion comes out of a narrow range and it is similar to the methodology of optimizing variables experimentally in terms of diversity of combustion. In this study, the combustion design methodology was developed that used the desired performance as input and derived combustion and combustion parameters as outputs in a diesel engine. The thermal efficiency, noise and emissions were needed to be calculated by 0-D combustion simulation for the combustion optimization. As a one of emission models, the 0-D soot model was developed through cooperative research with Youngbok Lee. The engine test that evaluated the soot emission by EGR rate, intake and coolant temperature was conducted to develop the 0-D soot model and acquire initial conditions for combustion design. The soot formation model was based on the simplified spray model to calculate the equivalence ratio at lift-off length. The equivalence ratio at the lift-off length was used as a one of the main factor for the soot formation model. In the combustion design process, IMEP represented the thermal efficiency. For the combustion noise evaluation, the combustion noise index was used. The 0-D NOx model from previous research was applied to estimate NOx emission. In the combustion design methodology, the initial parameters for constructing in-cylinder pressure were intake pressure, lambda and the mass faction burned. The MFB was determined by using Wiebe function and polynomial function as new approach to combustion phase. The mass of in-cylinder air and EGR rate were calculated from intake pressure, temperature, lambda, that were determined as initial conditions, and the chemical reaction equation. Compression and expansion strokes were assumed as polytropic process. The gas compositions during the combustion were calculated for calculation of polytropic index and other thermodynamic parameters. The in-cylinder pressure was calculated by the heat release rate and polytropic process with the estimated polytropic index. In the optimization process, the optimization algorithms used in the combustion design method were a minimum of constrained nonlinear multivariable function (interior-point) and particle swarm optimization. MATLAB was used as the optimization tool. The boundary conditions and constraints were determined for efficient iteration in optimization process. The base form of objective function for optimization allowed to find specific combustion of desired performance that was used as input. The objective functions for various design concepts were used in maximizing target performance. The results of combustion design were investigated by objective function and MFB function type at various operation point. The combustion design method was applied to WLTP by designing the steady points in WLTP operation region. The fuel consumption during WLTP decreased by 4.6% compared to experimental result The NOx and soot emissions could be reduced by 44.7% and 60.7%. In this study, the 0-D combustion simulation and optimization method that derived the combustion of desired performance were provided. This research can contribute to provide combustion shape with desired or optimized performance in combination with thermodynamic conditions, suggesting the development process different from existing research methods of engine and combustion strategies for target combustion.Chapter 1. Introduction 1 1.1 Background 1 1.2 Literature Review 8 1.2.1 Combustion noise model 8 1.2.2 NOx emission model 11 1.2.3 Soot emission model 13 1.2.4 Combustion optimization 18 1.3 Research Objectives and Contributions 28 1.4 Structure of the Thesis 29 Chapter 2. Experimental Apparatus 31 2.1 Experimental Setup 31 2.1.1 Test engine 31 2.1.2 Test cell and data acquisition systems 31 2.1.3 Emission measurement systems 32 2.1.4 Engine operating conditions 34 Chapter 3. Semi-physical 0-D Soot Model 46 3.1 Simplified Spray Model 46 3.1.1 Spray model description 46 3.1.2 Liquid length calculation 48 3.1.3 Laminar flame speed model 50 3.1.4 The equivalence ratio at the lift-off length 53 3.2 Semi-physical 0-D Soot Model 64 3.2.1 Soot formation model 64 3.2.2 Soot oxidation model 65 3.2.3 The model validation 68 Chapter 4. Other Models for Thermal Efficiency, Noise and NOx Emission 74 4.1 Thermal Efficiency 74 4.2 Noise โ€“ Combustion Noise Index (CNI) 74 4.3 The NOx Estimation Model 78 Chapter 5. Combustion Design Methodology 81 5.1 Concept of Combustion Design Method 81 5.2 Process of Constructing Combustion Pressure 86 5.2.1 Mass fraction burned and heat release rate 86 5.2.2 Calculation of in-cylinder air flow and EGR rate 95 5.2.3 Gas composition during the combustion process 102 5.2.4 Polytropic index and constructing cylinder pressure 103 5.2.5 Calculation of the fuel injection timing 107 5.3 Optimization Methodology 113 5.3.1 Optimization algorithms 113 5.3.2 Boundary conditions and constraints 116 5.3.3 Determination of the objective function 121 Chapter 6. Results of Combustion Design 131 6.1 Results from Base Objective Function 131 6.1.1 Low load: 1500 rpm, BMEP 4 bar 131 6.1.2 High load: 2000 rpm, BMEP 8 bar 136 6.2 Results by various design concept 141 6.3 Results Using Polynomial Function as MFB 148 6.4 Application of Combustion Design to WLTP 153 6.4.1 Combustion design at steady points in WLTP operating area 153 6.4.2 Results of an application to WLTP 164 Chapter 7. Conclusions 169 Bibliography 174 ๊ตญ ๋ฌธ ์ดˆ ๋ก 193๋ฐ•

    Smoking exposure and allergic rhinitis in children and adolescents

    Get PDF
    The prevalence of allergic rhinitis in children and adolescents is constantly increasing. However, few studies exist on the relationship between smoking and allergic rhinitis. In addition to conventional cigarettes, electronic and heated cigarettes have recently been introduced, which have several harmful effects. It is hypothesized that smoking and rhinitis are correlated; however, this relationship is complex. Previous studies reported that exposure to smoking during pregnancy is associated with allergic rhinitis development. Unlike the varied results reported in adults, studies on children and adolescents have often correlated direct/indirect smoke with allergic rhinitis, with prolonged exposure being associated with a higher risk of allergic rhinitis, particularly when exposed at an early age. Nonallergic inflammatory reactions and immunoglobulin E-mediated allergic sensitization are assumed to be the underlying mechanisms for the association between allergic rhinitis and smoking. Measures to reduce smoking are warranted to lower the incidence of allergic rhinitis in children and adolescents and to improve their health.ope

    Effects of Vacuuming Mattresses on Allergic Rhinitis Symptoms in Children

    Get PDF
    Purpose: To evaluate the effects of daily vacuuming of mattresses on the concentration of house dust mite (HDM) allergens and on allergic rhinitis (AR) symptoms in children sensitized to HDM. Methods: Forty children between the ages of 6 and 12 years with mild persistent AR and sensitized only to HDM were enrolled and randomly allocated to 2 groups. Caregivers of children in the experimental group cleaned the children's rooms and vacuumed their mattresses daily for 2 weeks. Caregivers of children in the control group cleaned the children's rooms without vacuuming mattresses. Symptoms of AR were checked weekly and dust samples were collected from the mattresses before and after the study. Results: Demographics at the beginning of the study were not significantly different between the 2 groups. In the experimental group, symptoms of AR and dust weight were significantly decreased after 2 weeks (total symptoms of AR, P <0.001; sneezing, P < 0.001; rhinorrhea, P <0.001; nasal obstruction, P < 0.001; itching, P <0.001; and dust weight, P = 0.006). The concentrations of HDM allergens were not changed significantly (Der p1, P = 0.333; Der f1, P = 0.841). In the control group, there were no significant changes in symptoms of AR, dust weight, or the concentration of HDM allergens. Conclusions: Our findings showed that daily vacuuming of mattresses reduced dust weight and symptoms of AR. However, the concentration of HDM allergens did not significantly decrease.ope

    Clinical Characteristics of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Korean Children: A Multicenter Retrospective Study

    Get PDF
    Mycoplasma pneumoniae is a major causative pathogen of community-acquired pneumonia in children, and the treatment of choice is macrolides. There is an increasing trend in reports of refractory clinical responses despite macrolide treatment due to the emergence of macrolide-resistant M. pneumoniae. Early discrimination of macrolide-refractory M. pneumoniae pneumonia (MrMP) from macrolide-sensitive M. pneumoniae pneumonia (MSMP) is vital; however, testing for macrolide susceptibility at the time of admission is not feasible. This study aimed to identify the characteristics of MrMP in Korean children, in comparison with those of MSMP. In this multicenter study, board-certified pediatric pulmonologists at 22 tertiary hospitals reviewed the medical records from 2010 to 2015 of 5294 children who were hospitalized with M. pneumoniae pneumonia and administered macrolides as the initial treatment. One-way analysis of variance and the Kruskal-Wallis test were used to compare differences between groups. Of 5294 patients (mean age, 5.6 years) included in this analysis, 240 (4.5%), 925 (17.5%), and 4129 (78.0%) had MrMP, macrolide-less effective M. pneumoniae pneumonia, and MSMP, respectively. Compared with the MSMP group, the MrMP group had a longer fever duration, overall (13.0 days) and after macrolide use (8.0 days). A higher proportion of MrMP patients had respiratory distress, pleural effusion, and lobar pneumonia. The mean aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, and C-reactive protein levels were the highest in the MrMP group, along with higher incidences of extrapulmonary manifestations and atelectasis (during and post infection). Pre-existing conditions were present in 17.4% (n = 725/4159) of patients, with asthma being the most common (n = 334/4811, 6.9%). This study verified that MrMP patients show more severe initial radiographic findings and clinical courses than MSMP patients. MrMP should be promptly managed by agents other than macrolides.ope

    ๊ณต์ž๋Š” ๋ฌด์‹ (๊ท€)๋ก ์ž์ธ๊ฐ€? - ๊ณต์ž์˜ ๊ท€์‹ ๋ก  ์žฌ๋ก  -

    Get PDF
    ใ€Ž๋…ผ์–ดใ€์—๋Š” ๊ท€์‹ ์„ ์–ด๋–ป๊ฒŒ ์„ฌ๊ฒจ์•ผ(ไบ‹) ํ•ฉ๋‹ˆ๊นŒ?"(ๅญฃ่ทฏๅ•ไบ‹้ฌผ็ฅž)๋ผ๋Š” ์ž๋กœ(๊ณ„๋กœ)์˜ ์งˆ๋ฌธ์ด ๊ธฐ๋ก๋˜์–ด ์žˆ๋‹ค. ์ผ๋ฐ˜์ ์œผ๋กœ ๊ทธ ์งˆ๋ฌธ์— ๋Œ€ํ•œ ๊ณต์ž์˜ ๋Œ€๋‹ต์€ ๊ท€์‹ ์˜ ์กด์žฌ์— ๊ด€ํ•œ ์œ ๊ต์˜ ์ž…์žฅ๏ผŒ ์ฆ‰ ์œ ๊ต์˜ ๋ฌด์‹ ๋ก ์  ์ž…์žฅ์„ ๋ณด์—ฌ์ฃผ๋Š” ๊ฒƒ์ด๋ผ๊ณ  ์ดํ•ด๋˜๊ณ  ์žˆ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ ๊ทธ ์งˆ๋ฌธ๊ณผ ๋Œ€๋‹ต์€ ๊ท€์‹ ์˜ ์กด์žฌ ์—ฌ๋ถ€๋ฅผ ๋‘˜๋Ÿฌ์‹ธ๊ณ  ์ด๋ฃจ์–ด์ง„ ๊ฒƒ์ด ์•„๋‹˜์„ ์•Œ ์ˆ˜ ์žˆ๋‹ค. ์ž๋กœ์˜ ์งˆ๋ฌธ์€ ๊ท€์‹ ์„ ์–ด๋–ป๊ฒŒ ์„ฌ๊ฒจ์•ผ(ไบ‹) ํ•˜๋Š”์ง€์— ๋Œ€ํ•œ ๊ฒƒ์ด๋‹ค. ์—ฌ๊ธฐ์„œ ์„ฌ๊ธด๋‹ค๋Š” ๋ง์˜ ์˜๋ฏธ๊ฐ€ ๋ฌธ์ œ๊ฐ€ ๋  ์ˆ˜ ์žˆ์ง€๋งŒ, ์–ด์จŒ๋“  ๊ทธ๊ฒƒ์€ ๊ท€์‹ ์ด ์กด์žฌํ•ฉ๋‹ˆ๊นŒ(์œ ๋ฌด)๋ผ๋Š” ์งˆ๋ฌธ์ด ์•„๋‹ˆ์—ˆ๋‹ค. ํ•˜์ง€๋งŒ ์ž๋กœ์™€ ๊ณต์ž์˜ ๋Œ€ํ™”๋Š” ๊ท€์‹ ์˜ ์กด์žฌ ์—ฌ๋ถ€์— ๊ด€ํ•œ ๊ฒƒ์œผ๋กœ ๋ฐ›์•„๋“ค์—ฌ์ ธ ์™”๋‹ค. ๋‚˜์•„๊ฐ€ ๊ณต์ž์˜ ๋Œ€๋‹ต์€ ๊ทธ์˜ ํ•ฉ๋ฆฌ์ฃผ์˜๏ผŒ ๋ฌด์‹ (๊ท€)๋ก ์„ ๋Œ€๋ณ€ํ•˜๋Š” ๋Œ€ํ‘œ์ ์ธ ๋ฐœ์–ธ์œผ๋กœ ํ•ด์„๋˜์–ด ์™”๋‹ค
    • โ€ฆ
    corecore